Brain Age

Brain age refers to a biological marker that estimates an individual’s brain health and aging trajectory, often deviating from their chronological age. It is typically derived from neuroimaging data, such as Magnetic Resonance Imaging (MRI), and comprehensive cognitive assessments. Machine learning models are trained on large datasets to predict a person’s age based on these brain characteristics, with the difference between the predicted brain age and chronological age (known as the brain age gap or BAG) serving as an indicator of accelerated or decelerated brain aging.

The biological basis of brain age is rooted in the complex processes of brain development and aging, which involve changes in brain structure (e.g., volume of gray and white matter, presence of white matter hyperintensities) and function (e.g., cognitive performance). These structural and functional brain aging characteristics are considered heritable, reproducible, and quantitative “endophenotypes”^[1]. They reflect underlying cellular and vascular brain aging processes ^[1]and are known to increase the risk of developing neurodegenerative conditions like dementia and stroke^[1]. Genetic factors play a significant role in influencing these endophenotypes, with genome-wide association studies (GWAS) being utilized to identify genes associated with brain aging ^[1].

Clinically, a higher brain age than chronological age (a positive brain age gap) has been associated with an increased risk for various neurological and psychiatric disorders, as well as general health decline. These brain aging endophenotypes can manifest years before the clinical and pathological diagnostic criteria for diseases such as dementia or stroke are met^[1], offering a potential avenue for early risk stratification. Understanding the genetic underpinnings through studies like GWAS can help detect novel susceptibility genes for brain aging and examine the relevance of candidate gene associations identified in animal models ^[1].

The social importance of brain age lies in its potential to contribute to personalized medicine and public health strategies, especially given the global aging population. By identifying individuals at higher risk for accelerated brain aging, it may be possible to implement targeted preventative interventions, lifestyle modifications, or earlier therapeutic strategies. Furthermore, research into the genetic and biological factors influencing brain age can lead to a deeper understanding of brain health, informing the development of new diagnostics and treatments for age-related brain diseases.

Methodological and Statistical Constraints

Research into brain age often faces limitations stemming from study design and statistical analysis. The genetic arrays used in some early studies, such as the 100K Affymetrix GeneChip, provided limited coverage of the genome, potentially missing significant genetic variations in key regions or specific candidate genes like APOE, ACE, Lamin A, SIRT2, and SIRT3. This incomplete genetic information can restrict the comprehensive understanding of genetic contributions to brain aging processes. Furthermore, the extensive number of tests performed in genome-wide association studies introduces significant multiple-testing issues, necessitating stringent statistical corrections that may be overly conservative or, conversely, lead to inflated effect sizes if not appropriately applied.

The findings from initial studies are often considered hypothesis-generating and require extensive replication in diverse and larger population samples to confirm their validity and generalizability. Many studies also contend with potential cohort biases, such as survival bias, where participants who live long enough to provide genetic samples may represent a healthier subset of the population. This can skew findings and limit their applicability to the broader spectrum of brain aging, particularly for pathological processes.

Generalizability and Phenotype Definition

A significant challenge for brain age research lies in the generalizability of findings across different populations and the precise definition of measured phenotypes. Studies conducted on cohorts with homogeneous ancestry, such as those predominantly of European descent, may not capture the full range of genetic diversity and thus cannot detect race or ethnicity-specific variations in gene-phenotype associations. This limits the universal applicability of identified genetic markers and necessitates further research in more diverse populations to ensure equitable scientific understanding.

Additionally, the reliance on cross-sectional endophenotypes, such as brain volumetric MRI and cognitive scores at a single point in time, may not fully encapsulate the dynamic and longitudinal nature of brain aging. While these endophenotypes are associated with increased risk for clinical conditions, the genetic factors influencing the progression of brain aging over decades might differ from those identified in static measures. Future research needs to explore how these genetic associations manifest across the lifespan and in response to various environmental influences.

Remaining Knowledge Gaps

Despite advances, significant knowledge gaps persist in fully understanding the genetic architecture of brain age. The current research is often hypothesis-generating, indicating that many identified genetic associations require further validation and mechanistic elucidation. While some studies identify biologically interesting genes, their precise roles and interactions within the complex biological pathways underlying brain aging remain largely unknown.

The intricate interplay between genetic predispositions and environmental factors is also not fully understood, leaving open questions about gene-environment interactions and their impact on brain age. Unaccounted environmental confounders could obscure or modify genetic effects, contributing to the “missing heritability” phenomenon where observed genetic variants explain only a fraction of the variation in brain aging. Bridging these gaps requires comprehensive longitudinal studies that integrate diverse data types, from genomics to detailed environmental exposures and lifestyle factors.

Variants

The genetic landscape influencing brain aging is complex, involving genes that regulate neuronal function, cellular stress responses, and developmental processes. Variations within these genes can subtly alter their activity, contributing to individual differences in brain health and cognitive trajectories over time. The following variants highlight key genetic contributions to brain age, reflecting roles in neuroprotection, cellular homeostasis, and regulatory pathways.

Several variants are found in genes or regions associated with neurodegeneration and the brain’s response to stress. For instance, rs2106786 is located in MAPT-AS1, an antisense RNA that regulates the MAPT gene. MAPTencodes the tau protein, which is central to the pathology of Alzheimer’s disease and other tauopathies. A variant here could influenceMAPT expression or splicing, thereby impacting tau protein levels or function, which are critical factors in neuronal health and brain aging. Similarly, rs593720 , associated with LINC02210-CRHR1, points to the CRHR1 gene, a receptor for corticotropin-releasing hormone. This gene plays a crucial role in the body’s stress response system (HPA axis), and genetic variations can modulate an individual’s resilience to stress, a known accelerator of brain aging. Another key player, KCNK2 (TREK-1), impacted by rs1452628 , encodes a potassium channel important for regulating neuronal excitability and neuroprotection; variants might affect its function, influencing how neurons cope with stress and age-related decline. Finally, rs12146713 in NUAK1 highlights a kinase involved in cellular growth and stress responses, with implications for neuronal survival pathways that are vital for maintaining brain integrity throughout life.

Other variants underscore the importance of fundamental cellular processes and brain development. The variant rs61067594 , located near GMNC and OSTN, involves GMNC, a gene essential for regulating the cell cycle, particularly DNA replication. Proper cell cycle control is vital for neural stem cell maintenance and repair mechanisms in the brain, making variations potentially relevant to brain regeneration and resilience. The KLF3 gene, affected by rs13132853 , and its antisense counterpart KLF3-AS1, with variant rs337638 , encode a transcriptional repressor and a regulatory non-coding RNA, respectively. KLF3 is involved in diverse cellular functions, including neuronal differentiation and metabolism, processes that profoundly influence brain structure and function over time. The SHH (Sonic Hedgehog) pathway, associated with rs371967302 , is a master regulator of embryonic brain development and continues to play roles in adult neurogenesis. Variations could subtly alter these developmental programs or adult neuroplasticity, influencing long-term cognitive health. Moreover, rs13135092 in SLC39A8 affects a zinc transporter, ZIP8. Zinc is an indispensable micronutrient for brain function, participating in neurotransmission, synaptic plasticity, and antioxidant defense, suggesting that variations impacting its transport could influence neuronal health and vulnerability to age-related damage.

The role of non-coding regions and pseudogenes also contributes to the intricate genetic architecture of brain aging. The variant rs534115641 is found in a region encompassing the pseudogenes DND1P1 and MAPK8IP1P2. While pseudogenes do not typically encode functional proteins, they can exert regulatory influence by producing non-coding RNAs or acting as microRNA sponges, thereby modulating the expression of their functional counterparts. MAPK8IP1 (JIP1), for instance, is a critical scaffold protein in neuronal signaling pathways, and its pseudogene might indirectly affect these processes. Additionally, the Y_RNA associated with rs371967302 represents a class of small non-coding RNAs involved in RNA processing and cellular stress responses. Variations in these regulatory elements could impact the efficiency of gene expression or the brain’s ability to cope with cellular stressors, ultimately influencing the rate of brain aging and cognitive decline.

Key Variants

RS ID	Gene	Related Traits
rs2106786	MAPT-AS1	erythrocyte count brain volume brain age measurement
rs534115641	DND1P1 - MAPK8IP1P2	brain age measurement
rs61067594	GMNC - OSTN	brain age measurement brain connectivity attribute brain attribute amygdala volume
rs13132853	KLF3	brain connectivity attribute neuroimaging measurement body fat percentage serum alanine aminotransferase amount triglyceride measurement
rs337638	KLF3-AS1	acute myeloid leukemia brain age measurement
rs371967302	SHH - Y_RNA	brain age measurement
rs593720	LINC02210-CRHR1, LINC02210, LINC02210	cerebral cortex area attribute brain age measurement
rs1452628	GAPDHP24 - KCNK2	cortical thickness cerebral cortex area attribute brain connectivity attribute brain attribute brain age measurement
rs13135092	SLC39A8	high density lipoprotein cholesterol measurement alcohol consumption quality, high density lipoprotein cholesterol measurement alcohol drinking, high density lipoprotein cholesterol measurement risk-taking behaviour cerebral cortex area attribute
rs12146713	NUAK1	cerebral cortex area attribute cortical thickness brain connectivity attribute thalamus volume white matter microstructure measurement

Classification, Definition, and Terminology

Brain age refers to the quantitative assessment of brain health and structure, often using neuroimaging and cognitive metrics, to reflect aspects of brain aging^[1]. It encompasses a range of phenotypic traits that capture structural and functional characteristics of the brain. These measures are frequently adjusted for intracranial volume and other covariates to provide a more precise reflection of brain aging ^[1].

Classification of Brain Aging Phenotypes

Brain aging phenotypes can be broadly classified into structural (volumetric MRI) and functional (cognitive testing) categories ^[1].

Structural Brain Aging Phenotypes (Volumetric MRI)

These phenotypes are derived from Magnetic Resonance Imaging (MRI) scans and quantify various brain regions and abnormalities. All MRI volumes are typically expressed as a ratio of total intracranial volume (TCV) ^[1].

Total Cerebral Brain Volume (ATCBV): Represents the overall volume of the cerebrum, indexed to intracranial volume ^[1].
Frontal Brain Volume (AFBV): The volume of the frontal lobes, indexed to intracranial volume ^[1].
Parietal Brain Volume (APBV): The volume of the parietal lobes, indexed to intracranial volume ^[1].
Occipital Brain Volume (AOBV): The volume of the occipital lobes, indexed to intracranial volume ^[1].
Temporal Brain Volume (ATBV): The volume of the temporal lobes, indexed to intracranial volume ^[1].
Hippocampal Volume (AHPV): The volume of the hippocampus, a brain region critical for memory, indexed to intracranial volume ^[1].
Lateral Ventricular Volume (ALVV): The combined volume of the lateral ventricles, which are fluid-filled cavities in the brain. These values are log-normalized and indexed over TCV ^[1].
Temporal Horn Volume (LTHBV): The combined volume of the temporal horns of the lateral ventricles. These values are log-normalized and indexed over TCV ^[1].
White Matter Hyperintensity Volume (BMRIZLWMHVMV):Refers to areas of increased signal intensity on MRI scans within the white matter, often associated with small vessel disease or aging. This measure is expressed as an age- and sex-specific Z-score of the logarithmically transformed continuous variable^[1].

Functional Brain Aging Phenotypes (Cognitive Testing)

These phenotypes assess various aspects of cognitive function that can decline with age ^[1].

Factor 1: Verbal Memory (F1): A composite measure reflecting verbal memory abilities ^[1].
Factor 2: Visual Memory and Organization (F2): A composite measure assessing visual memory and organizational skills ^[1].
Factor 3: Measure of attention and executive function-Trails A and B (F3): A composite measure evaluating attention and executive functions, often including tasks like the Trail Making Test ^[1].
Boston Naming Test (Nam): A test used to assess confrontational naming ability ^[1].
Similarities (Sim): A cognitive test measuring abstract verbal reasoning ^[1].
Wide-Range Achievement Test: A test that typically assesses basic academic skills ^[1].
Mini-Mental State Examination (MMSE):A widely used brief screening tool to assess cognitive impairment^[1].

Terminology

Total Intracranial Volume (TCV): The total volume of the cranial cavity, used as an index to normalize brain volumes and account for individual differences in head size ^[1].
Multivariable-Adjusted Residuals: Refers to the remaining variation in a trait after statistically accounting for the influence of multiple covariates such as age, sex, smoking status, diabetes, and blood pressure ^[1]. An ‘A’ preceding a trait name (e.g., ATCBV) indicates it is a multivariable adjusted residual ^[1].
Log-normalized: A mathematical transformation applied to data, typically to reduce skewness and stabilize variance, often used for traits like ventricular volumes ^[1].
Z-score: A standardized score indicating how many standard deviations an element is from the mean, used here for White Matter Hyperintensity Volume, specific to age and sex categories ^[1].
Endophenotypes:Measurable components that are intermediate between a disease and its genetic etiology, often used in research to identify genetic risk factors for complex conditions like neurodegenerative diseases^[1].

Biological Background for Brain Age

Brain aging involves complex biological processes that affect both the structure and function of the brain ^[2]. These changes can be observed through structural phenotypes, such as brain volume measurements from MRI, and functional phenotypes, assessed through cognitive testing ^[2]. These observable characteristics, known as endophenotypes, are considered heritable traits influenced by genes that may predispose an individual to diseases like dementia or stroke, often manifesting years before clinical diagnosis^[2].

Genetic and Heritable Factors

Research indicates a substantial genetic contribution to biological aging ^[3], with twin studies demonstrating the heritability of brain aging endophenotypes ^[2]. Genome-wide association studies (GWAS) aim to identify genes with modest effects on these phenotypes ^[2]. For instance, a genome-wide scan identified a specific locus on chromosome 4 linked to exceptional human longevity ^[4]. Another study found support for a locus near D4S1564 that promotes healthy aging ^[5]. Genes previously associated with conditions such as stroke, Alzheimer’s disease, and vascular dementia are considered relevant candidates for brain aging^[2].

Molecular and Cellular Pathways

Cellular and vascular processes are central to brain aging ^[2]. One significant molecular pathway implicated in longevity, and thus potentially in brain aging, is the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway^[6]. Identifying genes related to brain structure and function, including those previously linked to neurodegenerative and psychiatric conditions like Alzheimer’s disease and schizophrenia, helps in understanding the underlying biological mechanisms of brain aging in middle-aged to elderly populations^[2]. These genetic associations with endophenotypes may increase the risk of developing clinical conditions ^[2].

Clinical Relevance

The assessment of brain age holds significant clinical importance as its associated phenotypes can serve as early indicators of disease risk. These phenotypes, often heritable, reflect the genetic predispositions that can lead to various conditions, frequently manifesting years before the formal clinical and pathological diagnostic criteria are met.

Quantitative traits derived from volumetric brain Magnetic Resonance Imaging (MRI) and comprehensive cognitive testing are crucial in defining these indicators. These measures, such as Total Cerebral Brain Volume, Hippocampal Volume, Lateral Ventricular Volume, and White Matter Hyperintensity Volume, alongside cognitive test performance (e.g., MMSE and Verbal Memory), have been linked to an increased risk of developing conditions like dementia and stroke.

By identifying these brain aging phenotypes, researchers can investigate genes associated with stroke, Alzheimer’s disease, brain aging, and vascular dementia. This approach offers a pathway to understand the underlying genetic factors contributing to these neurological disorders and potentially to identify individuals at higher risk earlier in life.

Population Studies

Population studies are crucial for understanding the prevalence, risk factors, and genetic underpinnings of complex traits like brain aging. Research into brain age focuses on quantitative endophenotypes derived from structural brain imaging and cognitive assessments, which are considered heritable traits that may precede clinical disease manifestation^[1]. These endophenotypes are associated with the risk of developing conditions such as dementia or stroke^[1].

A significant population study utilized data from the Framingham Original and Offspring cohorts to investigate structural and functional brain aging phenotypes ^[1]. This study pooled data from the Original Cohort (Exam 26) and the Offspring Cohort (Exam 7) ^[1]. A total of 1345 individuals, belonging to 330 large families across these two cohorts, underwent genotyping for a Genome-Wide Association Study (GWAS) ^[1].

The brain aging phenotypes assessed in this population included a comprehensive set of volumetric Magnetic Resonance Imaging (MRI) measures and cognitive test performance ^[1]. Volumetric MRI traits included Total Cerebral Brain Volume (ATCBV), Frontal Brain Volume (AFBV), Parietal Brain Volume (APBV), Occipital Brain Volume (AOBV), Temporal Brain Volume (ATBV), and Hippocampal Volume (AHPV) ^[1]. Other structural measures included Lateral Ventricular Volume (ALVV), Temporal Horn Volume (LTHBV), and White Matter Hyperintensity Volume (BMRIZLWMHVMV), which was measured as an age- and sex-specific z-score of the log-normalized volume ^[1]. Cognitive function was assessed through tests, with Factor 1: Verbal Memory (F1) being a key phenotype ^[1].

These studies aim to identify genes with phenotypic effects on cellular and vascular brain aging and serve as a resource for replicating findings from other population-based samples and animal models of brain aging, stroke, and neurodegenerative diseases^[1].

Frequently Asked Questions About Brain Age Measurement

These questions address the most important and specific aspects of brain age measurement based on current genetic research.

1. Why does my friend’s memory seem sharper than mine at the same age?

Individual differences in cognitive performance can be influenced by your genetic makeup. Brain characteristics linked to aging and function, like cognitive performance, are considered heritable. Variations in genes that regulate neuronal health can subtly alter activity, contributing to these differences. This is why you might see varying cognitive trajectories even in people of the same chronological age.

2. Does my daily stress really make my brain age faster?

Yes, chronic stress can indeed accelerate brain aging. Genes like CRHR1, which is involved in your body’s stress response system, can have variations that influence your resilience to stress. These genetic differences, combined with environmental factors like persistent stress, are known accelerators of brain aging processes.

3. Can heavy exercise overcome my family’s history of brain issues?

While genetic factors play a significant role in your brain aging trajectory, lifestyle choices like regular exercise can absolutely help. Research shows that targeted preventative interventions and lifestyle modifications can potentially mitigate genetic predispositions. Understanding your genetic risk can help you implement strategies to support brain health, even with a family history of issues.

4. Can a brain scan actually tell me my brain’s true age?

Yes, a brain scan like an MRI, combined with cognitive assessments, can estimate your “brain age.” Machine learning models analyze characteristics from these scans to predict an age, and the difference from your chronological age is called the brain age gap. This gap serves as an indicator of how your brain’s health and aging trajectory compare to what’s typical.

5. Is there a test to see if I’m at risk for early dementia?

Yes, a higher brain age than your chronological age, indicated by a positive brain age gap, has been associated with an increased risk for neurodegenerative conditions like dementia. These “brain aging endophenotypes” can appear years before clinical symptoms. Understanding your brain age gap could offer a potential avenue for early risk stratification and intervention.

6. Does my ethnic background affect my brain aging risk?

Yes, your ethnic background can influence your brain aging risk. Many studies have focused on populations with homogeneous ancestry, which might miss genetic variations specific to other ethnic groups. This means that genetic markers identified in one population might not apply universally, highlighting the need for research across diverse populations to understand these differences.

7. Why do some people stay mentally sharp so much longer?

Individual differences in how people age mentally are significantly influenced by genetic factors. The structural and functional characteristics of brain aging, like gray and white matter volume, are considered heritable. Variations within genes that regulate neuronal function and cellular stress responses contribute to these different trajectories, allowing some to maintain sharpness longer.

8. Can eating healthy truly slow down how fast my brain ages?

Yes, adopting a healthy diet is considered a key lifestyle modification that can support brain health and potentially slow down accelerated brain aging. While genetic predispositions influence your trajectory, targeted preventative interventions, including dietary choices, are important public health strategies. They can help maintain cellular homeostasis and mitigate age-related brain decline.

9. My parents had memory problems; does that mean I will too?

Having parents with memory problems suggests you might have an increased genetic predisposition, as brain aging characteristics are heritable. Genetic factors play a significant role in influencing these endophenotypes, increasing the risk for conditions like dementia. However, it doesn’t mean it’s a definite outcome, as environmental factors and lifestyle also play a crucial role.

10. What would a brain age test tell me about my future health?

A brain age test would provide your brain age gap, indicating if your brain is aging faster or slower than your chronological age. A higher brain age gap is linked to an increased risk for various neurological and psychiatric disorders, as well as general health decline. This information could offer potential for early risk stratification and guide personalized preventative strategies for your future health.

This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.

Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.

References

[1] SS et al. “Genome-wide association study of structural and functional phenotypes previously associated with cellular and vascular brain aging.” BMC Medical Genetics, vol. 8, no. Suppl 1, 2007, p. S15.

[2] Seshadri, Sudha, et al. “Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study.” BMC Medical Genetics, vol. 8, suppl. 1, 2007, p. S15.

[3] Karasik, D., et al. “Genetic contribution to biological aging: the Framingham Study.” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 59, no. 3, 2004, p. 218.

[4] Puca, Annibale A., et al. “A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4.” Proceedings of the National Academy of Sciences, vol. 98, no. 18, 2001, p. 10505.

[5] Reed, T., et al. “Genome-wide scan for a healthy aging phenotype provides support for a locus near D4S1564 promoting healthy aging.” The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, vol. 59, no. 3, 2004, p. 227.

[6] Cheng, C. L., et al. “Role of insulin/insulin-like growth factor 1 signaling pathway in longevity.”World Journal of Gastroenterology, vol. 11, no. 13, 2005, p. 1891.